Rchr
J-GLOBAL ID:201801019188964231
Update date: Jun. 19, 2024
WATANABE Masahiro
ワタナベ マサヒロ | WATANABE Masahiro
Affiliation and department:
Research field (3):
Molecular biology
, Pharmacology
, Clinical pharmacy
Research theme for competitive and other funds (6):
- 2021 - 2024 内因性AGEによる組織リモデリング増悪化機構の解明と新規標的治療法の創成
- 2021 - 2024 炎症抑制性DAMPsの新規同定と炎症性疾患における病態生理学的意義の解明
- 2018 - 2021 Elucidation of the pathogenic mechanism of chronic inflammation based on AGE-induced cytokine trapping
- 2018 - 2021 Study of the pathophysiological significance of endogenous AGE as an exacerbating factor for tissue remodeling, and the development of novel targeted therapy
- 2015 - 2018 Roles of AGEs as exacerbation factor in pathogenesis of tissue remodeling and the development of novel targeted therapy
- 2015 - 2017 Elucidating the molecular bases and pathophysiological significances of the extracellular inflammasome which drives chronic inflammation
Show all
Papers (48):
-
Masahiro Watanabe, Takao Toyomura, Hidenori Wake, Takashi Nishinaka, Omer Faruk Hatipoglu, Hideo Takahashi, Masahiro Nishibori, Shuji Mori. Cationic ribosomal proteins can inhibit pro-inflammatory action stimulated by LPS+HMGB1 and are hindered by advanced glycation end products. Biotechnology and applied biochemistry. 2023
-
Takashi Nishinaka, Omer Faruk Hatipoglu, Hidenori Wake, Masahiro Watanabe, Takao Toyomura, Shuji Mori, Masahiro Nishibori, Hideo Takahashi. Different modulation of STING/TBK1/IRF3 signaling by advanced glycation end products. Archives of biochemistry and biophysics. 2023. 750. 109808-109808
-
Tatsuya Tai, Takaaki Yamamoto, Kazunori Yamaguchi, Masahiro Watanabe, Hiroaki Tanaka, Yuichi Muraki, Shinji Kosaka. Evaluation of the meropenem dosage and administration schedule in patients with bacteremia initial therapy. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023. 29. 8. 749-753
-
Takao Toyomura, Masahiro Watanabe, Hidenori Wake, Takashi Nishinaka, Omer Faruk Hatipoglu, Hideo Takahashi, Masahiro Nishibori, Shuji Mori. Glycolaldehyde-derived advanced glycation end products promote macrophage proliferation via the JAK-STAT signaling pathway. Molecular Biology Reports. 2023. 50. 7. 5849-5858
-
Omer Faruk Hatipoglu, Takashi Nishinaka, Masahiro Nishibori, Masahiro Watanabe, Takao Toyomura, Shuji Mori, Kursat Oguz Yaykasli, Hidenori Wake, Hideo Takahashi. Histamine promotes angiogenesis through a histamine H1 receptor-PKC-VEGF-mediated pathway in human endothelial cells. Journal of pharmacological sciences. 2023. 151. 4. 177-186
more...
MISC (76):
-
豊村隆男, 渡邊政博, 森秀治, 豊村隆男, 渡邊政博, 森秀治. Novel potential drug target for diabetic complications therapy, Glyoxalase I. 就実大学薬学雑誌. 2024. 11
-
山口 佳津騎, 田井 達也, 水岡 大策, 渡邊 政博, 阿部 武由, 越野 優希, 田中 裕章, 小坂 信二. バンコマイシンのAUCモニタリングにおける現状と課題 香川県内の病院を対象としたアンケート. TDM研究. 2022. 39. 2. 152-152
-
豊村 隆男, 渡邊 政博, 和氣 秀徳, 西中 崇, オメル・ハティポール, 高橋 英夫, 西堀 正洋, 森 秀治. グリコールアルデヒド由来AGEsによるマクロファージ増殖亢進. 日本薬学会年会要旨集. 2022. 142年会. 28PO1-18
-
TOYOMURA Takao, WATANABE Masahiro, MORI Shuji. TLR4-independent promotion of the osteoclast differentiation by detoxified LPS. 就実大学薬学雑誌. 2022. 9
-
田井達也, 山口佳津騎, 新村航, 松原亜季, 渡邊政博, 間嶋由美子, 横田恭子, 田中裕章, 小坂信二, 門脇則光. アミノ酸含有総合電解質輸液処方患者に対する投与速度適正化への取り組みが患者アウトカムに与える影響. 日本医療薬学会年会講演要旨集(Web). 2022. 32
more...
Books (3):
-
ラクトフェリン2019 ラクトフェリンの基盤的基礎研究の深化と応用開発研究の進化
アイ・ケイコーポレーション 2019
-
ZERO→ONE スタートアップTDM
南山堂 2019
-
ラクトフェリン2017 ラクトフェリンの医療分野での現状と今後への期待
アイ・ケイコーポレーション 2017
Works (1):
Education (3):
- - 2011 The University of Tokushima Graduate School of Pharmaceutical Sciences
- - 2006 The University of Tokushima Graduate School of Pharmaceutical Sciences
- - 2004 The University of Tokushima Faculty of Pharmaceutical Sciences School of Pharmacy
Professional career (1):
Work history (6):
Awards (1):
Return to Previous Page